U.S. Tobacco Stock News

If you are wondering whether KKR's current share price reflects its true worth, you are not alone. The stock's recent moves have raised fresh questions about value and risk. KKR closed at US$95.59, with returns of 2.1% over the past week, a 7.4% decline over 30 days, a 25.8% decline year to date, and a 17.2% decline over 1 year, while the 3 year and 5 year returns sit at 79.5% and 107.0% respectively. Recent headlines around KKR have focused on its role as a major global investment firm and...

If you are wondering whether Super Micro Computer's share price still reflects its true worth, you are not alone. The stock has been closely watched by investors focused on value. The shares last closed at US$32.24, with returns of a 0.5% decline over 7 days, a 4.5% decline over 30 days, a 4.1% gain year to date and a 15.7% decline over the past year, while the three year return is 247.6% and the five year return is roughly 8x. Recent news coverage has centered on Super Micro Computer's role...

LendingClub (NYSE:LC) has shifted from a marketplace only platform to a fully regulated US bank. The company has reported a period of strong revenue growth alongside a move from losses to profitability. This change alters how LendingClub funds loans and manages risk on its own balance sheet. LendingClub now trades at $15.14, with the stock up 32.8% over the past year and 83.3% over three years, despite a 20.8% decline year to date. That mix of gains and recent pullback gives investors a...

If you are wondering whether Lennar's share price reflects its real worth, this article will walk through what the current market price might be implying about the company's value. Lennar's stock closed at US$104.30, with returns of a 6.9% decline over 7 days, a 7.3% decline over 30 days, roughly flat at 0.1% year to date, and a 15.8% decline over 1 year, while the 3 year and 5 year returns sit at 19.6% and 33.5% respectively. Recent share price moves have kept Lennar on the radar for...

Arcosa (NYSE:ACA) announced the sale of its barge business and is shifting its focus toward construction materials and engineered structures. The move is aimed at concentrating resources on U.S. infrastructure and power related businesses that management views as core to the company. Arcosa, trading at $111.28 at the last close, is coming off a strong longer term stretch, with the stock up 37.0% over the past year and 87.8% over three years. The company is also ahead 76.5% over five years,...

Comments from McEwen (NYSE:MUX) chair and CEO Rob McEwen at the PDAC 2026 conference have put fresh attention on mining equities, as he pointed to a potential investor shift toward metals like gold and copper. See our latest analysis for McEwen. McEwen's comments at PDAC come at a time when the share price has pulled back in the short term, with a 1 day share price return showing a 6.39% decline and a 7 day share price return showing a 14.77% decline. However, the 90 day share price return of...

HA Sustainable Infrastructure Capital recently redeemed all US$450,000,000 of its 8.000% senior notes due 2027, using proceeds from new 6.000% green senior unsecured notes due 2036 and 7.125% green junior subordinated notes due 2056. This refinancing not only lengthens the company’s debt maturity profile but also aligns its funding base more closely with sustainability-focused investment projects. Next, we will examine how replacing higher‑coupon 2027 senior debt with longer‑dated green...

XPeng has launched its second generation Vision Language Action smart driving system, VLA 2.0, aimed at fully autonomous driving capabilities. Volkswagen will be the first external customer for VLA 2.0, marking a new technology partnership between the two automakers. XPeng plans to roll out fully autonomous robotaxis powered by VLA 2.0 as part of its commercial push in AI driven mobility. XPeng, listed as NYSE:XPEV, is putting this move in front of investors at a time when its share price...

Life Time Group Holdings (NYSE:LTH) has approved a new $500 million share repurchase program. The buyback plan targets the company's common stock and is intended to support long term shareholder value. This authorization adds a fresh capital allocation lever for the fitness and lifestyle operator. Life Time Group Holdings, trading at $26.12 per share, is coming off a mixed share price run, with a 51.2% gain over three years but a 13.3% decline over the past year. In the shorter term, the...

In late February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million with a quarterly net loss of US$108.12 million, and around the same time filed a US$300 million at-the-market follow-on equity offering plus a US$68.57 million shelf registration tied to an ESOP. Shortly after these filings, Director Blake Borgeson sold 170,000 Class A shares while still retaining more than 6.25 million shares, drawing attention to insider sentiment alongside the...

Huntington Bancshares at a glance Huntington Bancshares (HBAN) has drawn attention after recent share price weakness, with the stock down about 9% over the past month and modestly lower over the past 3 months. At a last close of $16.68, the regional bank carries a value score of 3 and reports annual revenue of $7,692.0 and net income of $2,087.0, both stated with positive annual growth rates. See our latest analysis for Huntington Bancshares. The recent 9.3% 30 day share price decline and...

Executives at Travelers Companies (NYSE:TRV) have recently carried out significant insider share sales, drawing attention to management's trading activity. The company has reported strong operating performance supported by underwriting gains, higher investment income, and efficiencies linked to AI tools. Travelers Companies sits at a current share price of $306.64. The stock is up 21.7% over the past year, 85.7% over the past 3 years, and 117.4% over the past 5 years. For investors looking...

In late February 2026, Stoke Therapeutics and Biogen reported in The New England Journal of Medicine that their investigational Dravet syndrome therapy zorevunersen produced substantial, durable reductions in seizures and multi‑year cognitive and behavioral benefits, while Stoke also outlined a Phase 3 EMPEROR timeline and plans for a rolling FDA submission. These clinical and regulatory updates suggest zorevunersen could shift treatment expectations in Dravet syndrome and intensify focus on...

Catalyst Pharmaceuticals (NasdaqCM:CPRX) reported record full year and Q4 2025 results, highlighting organic growth across its portfolio. The company noted continued market uptake of its lead rare disease treatments, including AGAMREE and FIRDAPSE. Management discussed how recent alliances and product momentum position Catalyst within the rare disease treatment space. Catalyst Pharmaceuticals focuses on therapies for rare neurological and neuromuscular conditions, an area where treatment...

AECOM (NYSE:ACM) has been selected by Sound Transit as the prime firm on several multi year contracts for major transit expansions in the Seattle region. The company will provide design, engineering, planning, and construction management services for new and upgraded light rail, commuter rail, and bus projects. These contracts position AECOM to play a central role in long term public transportation investments across the Pacific Northwest. For you as an investor, this new work reinforces...

In late February and early March 2026, ACADIA Pharmaceuticals reported higher full-year 2025 earnings, issued 2026 revenue guidance of US$1.22–1.28 billion, received a negative CHMP opinion on trofinetide for Rett syndrome in the EU, and added experienced finance executive Jonathan M. Poole to its Board and Audit Committee. The CHMP’s refusal of trofinetide, despite a pivotal trial meeting its key endpoints, raises important questions about ACADIA’s ability to expand Rett syndrome treatment...

INVO Fertility has joined the Progyny (NasdaqGS:PGNY) provider network, adding its clinic to Progyny's fertility benefits platform. The partnership expands access to employer sponsored fertility care for patients in Wisconsin and nearby regions. This development broadens Progyny's provider footprint and increases potential touchpoints with covered employees seeking fertility treatment. Progyny runs a fertility benefits platform that connects employer sponsored health plans with a network of...

In early March 2026, Roblox Corporation rolled out AI-driven real-time chat rephrasing and upgraded text filters to keep in-game conversations civil while more accurately detecting attempts to bypass its Community Standards across multiple languages and age-checked groups. This push to make communication smoother and safer highlights how central trust and moderation technology have become to Roblox’s effort to support large-scale user engagement and creator-driven experiences. Next, we'll...

If you are wondering whether PNC Financial Services Group's current share price lines up with its underlying worth, you are in the right place for a clear, valuation focused look at the stock. The shares last closed at US$212.37, after a 4.7% decline over the past week and a 9.2% decline over the past month, while the 1 year return sits at 23.0% and the 3 year return at 73.6%. These moves come as investors continue to weigh broader sentiment toward large US banks and react to ongoing sector...

Medical Properties Trust (NYSE:MPT) has issued a response to Prospect Medical Group's bankruptcy filing. The company is outlining potential operational impacts related to Prospect's tenant status and leased hospital assets. Investors are watching for updates on rental income exposure, asset utilization, and any changes to existing lease arrangements. Medical Properties Trust focuses on owning and leasing hospital and healthcare facilities, so any disruption involving a key tenant like...

Cognizant Technology Solutions recently reshuffled its leadership in Asia Pacific & Japan, renewed a multi-million-dollar digital transformation partnership with Travel + Leisure Co., expanded its Google Cloud collaboration to scale agentic AI, and secured a multi-year AI-powered workplace modernization deal with a leading commercial vehicle manufacturer. Together, these moves highlight Cognizant’s push to embed AI and automation more deeply into large, long-term client relationships across...

Innodata (INOD) is back in focus after reporting fourth quarter and full year 2025 results, alongside fresh 2026 revenue guidance. See our latest analysis for Innodata. Even with the fresh 2026 revenue outlook, Innodata’s recent share price performance has cooled, with a 30 day share price return showing an 18.35% decline and a 90 day share price return showing a 23.14% decline, while the three year total shareholder return remains very large. If this earnings update has you thinking about...

Why Wendy's restructuring move matters for shareholders Wendy's (WEN) is shaking up its footprint, planning to close 200 to 300 underperforming US restaurants while backing more than 60 new franchise led openings in Mexico following weak domestic same store sales. See our latest analysis for Wendy's. That restructuring push comes after a tough run for shareholders, with the share price at US$7.25 and recent momentum fading, including a 90 day share price return decline of 14.1% and a 1 year...

Leonardo DRS (DRS) is back in focus after quarterly revenue and earnings topped expectations, supported by US$1.1b of new contract awards, higher 2026 revenue guidance and fresh recognition for its technology leadership. See our latest analysis for Leonardo DRS. The latest move takes the share price to US$45.82, after a 10.38% 1 month share price return and a 35.16% 3 month share price return. The 1 year total shareholder return of 55.08% and very large 3 year total shareholder return of...